Effects of Replacement Therapy With Sexual Steroid Hormones on the Insulin Sensitivity of Hypogonadal Man
- Conditions
- Hypogonadism
- Interventions
- Biological: Testosterone (Insulin sensitivity)Biological: Estradiol (Insulin sensitivity)
- Registration Number
- NCT02847806
- Lead Sponsor
- University Hospital, Caen
- Brief Summary
Sexual steroids administered to supra-physiological doses are likely to change the carbohydrate and lipid metabolism.
Investigators propose to study in 12 hypogonadal men hypogonadotropic or hypergonadotropic treated with aromatase inhibitor, the respective effects of estradiol, testosterone or both steroids administered in a cross-over Latin squares plan on insulin sensitivity measured by the reference method of the hyperinsulinemic euglycemic clamp.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 6
- Hypogonadism hypogonadotropic or hypergonadotropic
- Man aged 18-60 years
- BMI between 18 and 27.
- Other ante-pituitary deficiency
- Chronic treatment modifying carbohydrate metabolism (thiazides, beta 2 mimetics, steroids ...)
- Diabetes
- Obesity diffuse or android
- Hemochromatosis
- osteoporosis
- chronic diseases
- neoplasia
- High blood pressure
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description Testosterone Testosterone (Insulin sensitivity) dosage used : from 25 to 75 mg / day of testosterone (ie 2.5 to 7.5 g / day transdermal gel) according to the plasma level, with the goal of a physiological level of testosterone (5-8 ng / ml) - During 4 weeks Testosterone + Estradiol Estradiol (Insulin sensitivity) Testosterone + Estradiol During 4 weeks Estradiol Estradiol (Insulin sensitivity) dosage used in the study: 1 patch / 3-4 days dosed at 25, 37.5 or 50 mg / 24h titration according to the plasma level, with the objective of a physiological level of estradiol (25-40 pg / ml ) - During 4 weeks Testosterone + Estradiol Testosterone (Insulin sensitivity) Testosterone + Estradiol During 4 weeks
- Primary Outcome Measures
Name Time Method GIR (glucose infusion rate) during euglycemic hyperinsulinemic clamp change between baseline and after 4 weeks of treatments
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Endocrinology Unit and Clinical Research Center Basse Normandie, University Hospital of Caen
🇫🇷Caen, France